| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 208,040 | 203,247 | 203,448 | 194,178 | | Cost of Revenue | 170,020 | 162,798 | 162,014 | 157,451 | | | Gross Profit | 38,020 | 40,449 | 41,434 | 36,727 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,813 | 23,941 | 23,168 | 23,625 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,727 | 3,770 | 3,882 | 3,727 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,480 | 12,738 | 14,384 | 9,375 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3 | 4 | 16 | 36 | | Earnings Before Interest And Taxes | 10,535 | 12,850 | 14,566 | 10,088 | | Interest Expense | 498 | 549 | 572 | 745 | | Income Before Tax | 10,037 | 12,301 | 13,994 | 9,343 | | Income Tax Expense | 4,331 | 4,928 | 5,540 | 3,371 | | Minority Interest |
-
|
-
|
-
| 647 | | | | Net Income From Continuing Ops | 5,706 | 7,373 | 8,454 | 5,972 | | | Non-recurring Events | | Discontinued Operations | 831 | (825) | (6) | (269) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,304 | 6,548 | 8,448 | 5,703 | | Preferred Stock And Other Adjustments | (547) | 335 | 212 |
-
| | | Net Income Applicable To Common Shares | $6,757 | $6,883 | $8,660 | $5,703 |
|
0.07% Nasdaq 
0.10 (0.32%) 
Income Statement
